The company may offer from time to time in one or more offerings up to an aggregate of $150M of common stock, preferred stock, debt securities, warrants or units, separately or together in one or more combinations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSO:
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
- CytoSorbents to present at inaugural AAPI World Health Congress
- CytoSorbents secures $20M credit facility
- CytoSorbents Secures $20 Million Credit Facility
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan